Literature DB >> 12412833

Development and consequences of cannabis dependence.

Alan J Budney1, Brent A Moore.   

Abstract

The past 10 to 15 years of clinical and basic research have produced strong evidence demonstrating that cannabis can and does produce dependence. Clinical and epidemiological studies indicate that cannabis dependence is a relatively common phenomenon associated with significant psychosocial impairment. Basic research has identified a neurobiological system specific to the actions of cannabinoids. Human and nonhuman studies have demonstrated a valid withdrawal syndrome that is relatively common among heavy marijuana users. Last, clinical trials evaluating treatments for cannabis dependence suggest that this disorder, like other substance dependence disorders, is responsive to intervention, yet the majority of patients have difficulty achieving and maintaining abstinence. Of concern, treatment seeking for marijuana dependence has increased almost twofold over the past 10 years. This report briefly reviews selected research literature relevant to our current understanding of cannabis dependence, its associated consequences, and treatment efficacy.

Entities:  

Mesh:

Year:  2002        PMID: 12412833     DOI: 10.1002/j.1552-4604.2002.tb06000.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  19 in total

Review 1.  State of the art treatments for cannabis dependence.

Authors:  Itai Danovitch; David A Gorelick
Journal:  Psychiatr Clin North Am       Date:  2012-04-10

Review 2.  Medical consequences of marijuana use: a review of current literature.

Authors:  Adam J Gordon; James W Conley; Joanne M Gordon
Journal:  Curr Psychiatry Rep       Date:  2013-12       Impact factor: 5.285

3.  Orbitofrontal and caudate volumes in cannabis users: a multi-site mega-analysis comparing dependent versus non-dependent users.

Authors:  Yann Chye; Nadia Solowij; Chao Suo; Albert Batalla; Janna Cousijn; Anna E Goudriaan; Rocio Martin-Santos; Sarah Whittle; Valentina Lorenzetti; Murat Yücel
Journal:  Psychopharmacology (Berl)       Date:  2017-04-01       Impact factor: 4.530

4.  Thinking Beyond Legalization: The Case for Expanding Evidence-Based Options for Cannabis Use Disorder Treatment in Canada.

Authors:  Didier Jutras-Aswad; Bernard Le Foll; Julie Bruneau; T Cameron Wild; Evan Wood; Benedikt Fischer
Journal:  Can J Psychiatry       Date:  2018-07-22       Impact factor: 4.356

Review 5.  Cannabinoid and opioid interactions: implications for opiate dependence and withdrawal.

Authors:  J L Scavone; R C Sterling; E J Van Bockstaele
Journal:  Neuroscience       Date:  2013-04-24       Impact factor: 3.590

6.  Psychosocial functioning among regular cannabis users with and without cannabis use disorder.

Authors:  Katherine T Foster; Brooke J Arterberry; William G Iacono; Matt McGue; Brian M Hicks
Journal:  Psychol Med       Date:  2017-11-27       Impact factor: 7.723

7.  A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.

Authors:  Kevin M Gray; Susan C Sonne; Erin A McClure; Udi E Ghitza; Abigail G Matthews; Aimee L McRae-Clark; Kathleen M Carroll; Jennifer S Potter; Katharina Wiest; Larissa J Mooney; Albert Hasson; Sharon L Walsh; Michelle R Lofwall; Shanna Babalonis; Robert W Lindblad; Steven Sparenborg; Aimee Wahle; Jacqueline S King; Nathaniel L Baker; Rachel L Tomko; Louise F Haynes; Ryan G Vandrey; Frances R Levin
Journal:  Drug Alcohol Depend       Date:  2017-06-10       Impact factor: 4.492

8.  Cannabis withdrawal in adolescent treatment seekers.

Authors:  Ryan Vandrey; Alan J Budney; Jody L Kamon; Catherine Stanger
Journal:  Drug Alcohol Depend       Date:  2004-12-18       Impact factor: 4.492

9.  Marijuana withdrawal and craving: influence of the cannabinoid receptor 1 (CNR1) and fatty acid amide hydrolase (FAAH) genes.

Authors:  Heather M Haughey; Erin Marshall; Joseph P Schacht; Ashleigh Louis; Kent E Hutchison
Journal:  Addiction       Date:  2008-08-14       Impact factor: 6.526

10.  Achieving cannabis cessation -- evaluating N-acetylcysteine treatment (ACCENT): design and implementation of a multi-site, randomized controlled study in the National Institute on Drug Abuse Clinical Trials Network.

Authors:  Erin A McClure; Susan C Sonne; Theresa Winhusen; Kathleen M Carroll; Udi E Ghitza; Aimee L McRae-Clark; Abigail G Matthews; Gaurav Sharma; Paul Van Veldhuisen; Ryan G Vandrey; Frances R Levin; Roger D Weiss; Robert Lindblad; Colleen Allen; Larissa J Mooney; Louise Haynes; Gregory S Brigham; Steve Sparenborg; Albert L Hasson; Kevin M Gray
Journal:  Contemp Clin Trials       Date:  2014-08-30       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.